Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: A [ 11C]DASB PET study

Molecular Psychiatry

Volumn 13, Issue 6, 2008, Pages 606-613

  Reimold, M ^a   Batra, A ^b   Knobel, A ^c   Smolka, M N ^d   Zimmer, A ^d   Mann, K ^d   Solbach, C ^a   Reischl, G ^a   Schwarzler F ^a   Grunder G ^e   Machulla, H J ^a   Bares, R ^a   Heinz, A ^c,d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

BDI; Negative mood states; PET; Serotonin transporter; STAI; Thalamus

Indexed keywords

AMINO 4 (2 DIMETHYLAMINOMETHYLPHENYLSULFANYL) BENZONITRILE C 11; RADIOLIGAND; SEROTONIN TRANSPORTER;

ADULT; AMYGDALOID NUCLEUS; ANXIETY; ANXIETY DISORDER; ARTICLE; BECK DEPRESSION INVENTORY; BRAIN CORTEX; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GENOTYPE; HEALTH STATUS; HUMAN; HYPOTHESIS; IN VIVO STUDY; MAJOR DEPRESSION; MALE; MESENCEPHALON; MOOD DISORDER; NERVE CELL EXCITABILITY; PERSONALITY TEST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BINDING; SEROTONINERGIC SYSTEM; SMOKING; STATE TRAIT ANXIETY INVENTORY; STATISTICAL SIGNIFICANCE; THALAMUS;

ANXIETY; BENZYLAMINES; BRAIN; CARBON RADIOISOTOPES; CEREBELLUM; DEPRESSIVE DISORDER; HUMANS; INTERVIEWS AS TOPIC; POSITRON-EMISSION TOMOGRAPHY; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; THALAMUS;

EID: 43949111033     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/sj.mp.4002149     Document Type: Article

References (51)

1. Meltzer H, Bastani B, Jayathilake K, Maes M. Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder. Neuropsychopharmacology 1997; 17: 1-11.
2. 11C]DASB positron emission tomography study. Am J Psychiatry 2004; 161: 826-835.
3. Pirker W, Asenbaum S, Kasper S, Walter H, Angelberger P, Koch G et al. Beta-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo. J Neural Transm Gen Sect 1995; 100: 247-256.
4. Asberg M, Thoren P, Traskman L, Bertilsson L, Ringberger V. 'Serotonin depression' - a biochemical subgroup within the affective disorders? Science 1976; 191: 478-480.
5. Asberg M, Bertilsson L, Martensson B, Scalia-Tomba GP, Thoren P, Traskman-Bendz L. CSF monoamine metabolites in melancholia. Acta Psychiatr Scand 1984; 69: 201-219.
6. 123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 1998; 44: 1090-1098.
7. Staley JK, Sanacora G, Tamagnan G, Maciejewski PK, Malison RT, Berman RM et al. Sex differences in diencephalon serotonin transporter availability in major depression. Biol Psychiatry 2006; 59: 40-47.
8. 123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol Psychiatry 2000; 47: 482-489.
9. 123I]b-CIT: pharmacological characterization of brain uptake in non-human primates. Synapse 1993; 13: 295-309.
10. Heinz A, Jones DW, Zajicek K, Gorey JG, Juckel G, Higley JD et al. Depletion and restoration of endogenous monoamines affects β-CIT binding to serotonin but not dopamine transporters in non-human primates. J Neural Transm 2004; 68(Suppl): 29-38.
11. Heinz A, Higley JD, Gorey JG, Saunders RC, Jones DW, Hommer D et al. In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in nonhuman primates. Am J Psychiatry 1998; 155: 1023-1028.
12. Heinz A, Jones DW, Ragan P, Hommer D, Knable MB, Weinberger DR et al. Relationship between cortisol and serotonin metabolites and transporters in alcoholism. Pharmacopsychiatry 2002; 35: 127-134.
13. Seibyl JP, Wallace E, Smith EO, Stabin M, Baldwin RM, Zoghbi S et al. Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-beta-CIT in healthy human subjects. J Nucl Med 1994; 35: 764-770.
14. 11C]beta-CFT in early Parkinson's disease. Synapse 1995; 21: 97-103.
15. Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M et al. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging. J Nucl Med 2000; 41: 36-44.
16. Hummerich R, Schulze O, Radler T, Mikecz P, Reimold M, Brenner W et al. Inhibition of serotonin transport by (+)McN5652 is noncompetitive. Nucl Med Biol 2006; 33: 317-323.
17. Parsey RV, Hastings RS, Oquendo MA, Huang YY, Simpson N, Arcement J et al. Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am J Psychiatry 2006; 163: 52-58.
18. 11C](+)McN5652. Biol Psychiatry 2002; 51: 715-722.
19. 11C-McN 5652 in healthy humans. J Nucl Med 2004; 45: 682-694.
20. 11C]DASB. Eur J Nucl Med 2000; 27: 1719-1722.
21. Hummerich R, Reischl G, Ehrlichmann W, Machulla HJ, Heinz A, Schloss P. DASB - in vitro binding characteristics on human recombinant monoamine transporters with regard to its potential as a PET tracer. J Neurochem 2004; 90: 1218-1226.
22. Meyer JH, Houle S, Sagrati S, Carella A, Hussey DF, Ginovart N et al. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Arch Gen Psychiatry 2004; 61: 1271-1279.
23. Meyer JH. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J Psychiatry Neurosci 2007; 32: 86-102.
24. 123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse 2001; 41: 275-284.
25. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-1531.
26. Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, Hommer D et al. Serotonin transporter genotype interacts with in vivo protein expression and chronic alcohol intake. Biol Psychiatry 2000; 47: 643-649.
27. 123I]beta-CIT SPECT in relation to serotonin transporter genotype. Am J Psychiatry 2004; 161: 525-531.
28. 11C]DASB is affected by serotonin transporter genotype. J Neural Transm 2007; 114: 635-639.
29. 11C]DASB positron emission tomography study. Biol Psychiatry 2007; 62: 327-331.
30. First MB, Spitzer RL, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition With Psychotic Screen. Biometrics Research, New York State Psychiatric Institute: New York, 2001.
31. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
32. Hautzinger M, Bailer M, Worall H, Keller F. Beck Depressionsinventar (BDI). Huber: Bern, 1994.
33. Laux LT, Glanzmann P, Schaffner P, Spielberger CD. Das State-Trait-Angstinventar (STAI). Beltz: Weinheim, 1981.
34. Cloninger CR, Przybeck TR, Svrakic DM, Wetzel RD. The Temperament and Character Inventory (TCI): A guide to its Development and Use. Center for Psychobiology of Personality: St Louis, MO, 1994.
35. First MB, Spitzer RL, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II). American Psychiatric Press: Washington, DC, 1997.
36. 11C]DASB and application in a remote-controlled high yield synthesis. Radiochim Acta 2004; 92: 341-344.
37. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 2003; 23: 1096-1112.
38. 11C]DASB and positron emission tomography. Biol Psychiatry 2006; 59: 821-828.
39. Reimold M, Slifstein M, Heinz A, Müller-Schauenburg W, Bares R. Effect of spatial smoothing on t-maps: arguments for going back from t-maps to masked contrast images. J Cereb Blood Flow Metab 2006; 26: 751-759.
40. McCormick DA. Neurotransmitter actions in the thalamus and cerebral cortex. J Clin Neurophysiol 1992; 9: 212-223.
41. 11C]DASB PET imaging study. Am J Psychiatry 2001; 158: 1843-1849.
42. 18F]setoperone PET imaging study. Am J Psychiatry 2001; 158: 78-85.
43. Benmansour S, Owens WA, Cecchi M, Morilak DA, Frazer A. Serotonin clearance in vivo is altered to a greater extent by antidepressant- induced downregulation of the serotonin transporter than by acute blockade of this transporter. J Neurosci 2002; 22: 6766-6772.
44. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D et al. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002; 297: 400-403.
45. Hariri AR, Drabant EM, Munoz KE, Kolachana BS, Mattay VS, Egan MF et al. A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry 2005; 62: 146-152.
46. Heinz A, Braus DF, Smolka MN, Wrase J, Puls I, Hermann D et al. Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci 2005; 8: 20-21.
47. Hansen HH, Sanchez C, Meier E. Neonatal administration of the selective serotonin reuptake inhibitor Lu 10-134-C increases forced swimming-induced immobility in adult rats: a putative animal model of depression? J Pharmacol Exp Ther 1997; 283: 1333-1341.
48. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005; 8: 828-834.
49. Hasler G, Drevets WC, Manji HK, Charney DS. Discovering endophenotypes for major depression. Neuropsychopharmacology 2004; 29: 1765-1781.
50. Knutson B, Wolkowitz OM, Cole SW, Chan T, Moore EA, Johnson RC et al. Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry 1998; 155: 373-379.
51. Spillmann MK, Van der Does AJ, Rankin MA, Vuolo RD, Alpert JE, Nierenberg AA et al. Tryptophan depletion in SSRI-recovered depressed outpatients. Psychopharmacology 2001; 155: 123-127.